SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
+19.55%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$7B
AUM Growth
+$1.46B
(+26%)
Cap. Flow
+$835M
Cap. Flow
% of AUM
11.93%
Top 10 Holdings %
Top 10 Hldgs %
35.33%
Holding
137
New
43
Increased
38
Reduced
15
Closed
29
Top Buys
| 1 |
Netflix
NFLX
|
$152M |
| 2 |
UnitedHealth
UNH
|
$142M |
| 3 |
Dynatrace
DT
|
$94.3M |
| 4 |
Exact Sciences
EXAS
|
$81M |
| 5 |
Opendoor
OPEN
|
$79.4M |
Top Sells
| 1 |
PayPal
PYPL
|
$106M |
| 2 |
Amphenol
APH
|
$99.8M |
| 3 |
Amazon
AMZN
|
$97.6M |
| 4 |
GAP
The Gap, Inc.
GAP
|
$96.2M |
| 5 |
Copart
CPRT
|
$71M |
Sector Composition
| 1 | Technology | 22.5% |
| 2 | Healthcare | 21.05% |
| 3 | Consumer Discretionary | 16.78% |
| 4 | Industrials | 15.25% |
| 5 | Communication Services | 11.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPOD
51
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
| $24.6M | 0.35% |
+1,800,000
| New | +$24.6M |
|
52
Sutro Biopharma
STRO
$90.7M
| $22.5M | 0.32% |
1,035,409
-134,757
| -12% | -$2.93M |
|
|
BLUE
53
DELISTED
bluebird bio
BLUE
| $18.5M | 0.26% |
+32,972
| New | +$18.5M |
|
|
MILE
54
DELISTED
Metromile, Inc. Common Stock
MILE
| $17.9M | 0.26% |
+1,149,520
| New | +$17.9M |
|
|
MRNS
55
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $17.4M | 0.25% |
1,430,172
+650,447
| +83% | +$7.94M |
|
56
Allogene Therapeutics
ALLO
$255M
| $12.2M | 0.17% |
+483,200
| New | +$12.2M |
|
57
Immunovant
IMVT
$2.87B
| $12M | 0.17% |
259,200
-276,084
| -52% | -$12.8M |
|
58
Forte Biosciences
FBRX
$136M
| $11.8M | 0.17% |
+13,000
| New | +$11.8M |
|
59
Insmed
INSM
$30B
| $11.2M | 0.16% |
337,145
| – | – |
|
60
Soleno Therapeutics
SLNO
$3.7B
| $11.1M | 0.16% |
383,880
+168,763
| +78% | +$4.89M |
|
|
FSDC
61
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| $9.89M | 0.14% |
899,457
+549,457
| +157% | +$6.04M |
|
|
MREO
62
Mereo BioPharma
MREO
$280M
| $9.84M | 0.14% |
+2,748,999
| New | +$9.84M |
|
63
Kura Oncology
KURA
$724M
| $8.87M | 0.13% |
271,500
+152,500
| +128% | +$4.98M |
|
64
Oric Pharmaceuticals
ORIC
$1.08B
| $8.56M | 0.12% |
+252,910
| New | +$8.56M |
|
|
KDNY
65
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $8.35M | 0.12% |
526,455
+298,199
| +131% | +$4.73M |
|
66
Agios Pharmaceuticals
AGIO
$2.19B
| $8.25M | 0.12% |
+190,300
| New | +$8.25M |
|
|
MRACU
67
DELISTED
Marquee Raine Acquisition Corp. Unit
MRACU
| $8.12M | 0.12% |
+750,000
| New | +$8.12M |
|
68
Prelude Therapeutics
PRLD
$65.7M
| $7.95M | 0.11% |
111,065
-113,935
| -51% | -$8.15M |
|
69
Kezar Life Sciences
KZR
$28M
| $7.36M | 0.11% |
140,996
+85,406
| +154% | +$4.46M |
|
|
ASTR
70
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $6.05M | 0.09% |
39,867
-60,133
| -60% | -$9.12M |
|
71
Spyre Therapeutics
SYRE
$1.05B
| $5.97M | 0.09% |
30,350
+9,186
| +43% | +$1.81M |
|
72
KalVista Pharmaceuticals
KALV
$780M
| $5.87M | 0.08% |
308,900
| – | – |
|
73
Milestone Pharmaceuticals
MIST
$154M
| $5.7M | 0.08% |
+851,291
| New | +$5.7M |
|
|
HAACU
74
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
| $5.51M | 0.08% |
+500,000
| New | +$5.51M |
|
75
Foghorn Therapeutics
FHTX
$304M
| $5.24M | 0.07% |
+258,700
| New | +$5.24M |
|